Spectral Correlates of Impulsivity in Patients With Traumatic Brain Injury
NCT ID: NCT04239274
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-01-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Transcranial Direct Current Stimulation (tDCS) and Cognitive Training in Patients With TBI
NCT04540783
Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury
NCT02849223
CONsciousness Transcranial Electric STimulation
NCT03576248
Theta Burst Transcranial Magnetic Stimulation of Fronto-parietal Networks: Modulation by Mental State
NCT04010461
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 1
NCT03896425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcranial Direct Current Stimulation (tDCS)
transcranial direct current stimulation
Subjects in this arm will receive one session of tDCS for 20 minutes at 2.0 milliamps.
Transcranial Pulsed Stimulation tPCS
transcranial pulsed current stimulation
Subjects in this arm will receive one session of tPCS for 20 minutes at 2.0 milliamps.
No Stimulation
Sham-no stimulation
Subjects in this arm will receive one session of sham for 20 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial direct current stimulation
Subjects in this arm will receive one session of tDCS for 20 minutes at 2.0 milliamps.
transcranial pulsed current stimulation
Subjects in this arm will receive one session of tPCS for 20 minutes at 2.0 milliamps.
Sham-no stimulation
Subjects in this arm will receive one session of sham for 20 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is at least 3 months post-injury at the time of consent
* Ages 25-70
Exclusion Criteria
* Subjects with body habitus that does not allow the EEG cap to be properly placed
* Presence of scalp injury or disease
* Allergic reaction to topical lidocaine jelly
* Prior intracranial surgery or skull-fracture over VLPFC
* Presence of hemorrhage on intracranial imaging
* Prior brain radiotherapy
* Prior history of intracranial tumor, intracranial infection, or cerebrovascular malformation
* Subjects with the inability to see and read from a computer screen
* History of any form of seizures prior to TBI or within 6 months of study participation
* Pregnancy
25 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan Rowland
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathan Rowland, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00093356
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.